Itron, Inc. (ITRI)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-09-15
$92.30+0.45%
Close 2026-09-15 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-09-15
Research Workspace
Put ITRI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Electronic Equipment & Instruments is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue near $2.4 billion in FY 2026: FY26 revenue guidance $2.39B vs $2.4B target.
View ThesisRevenue is contracting — down about 6% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 21%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 44% in its worst 12-month stretch.
View RiskItron's growth in the Outcomes segment has to keep compounding to justify the price. Revenue guidance for FY 2026 is $2.39 billion, just below the $2.4 billion target. ITRI trades at 13× P/E versus a peer median of 30×. This suggests the price reflects less growth than we forecast. The primary risk is a potential guidance cut on the next call, which could negatively impact estimates. Peer multiples imply a price about 32% above where it trades. Our read is provisional.
Trailing returns as of 2026-09-15. ITRI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 12 analysts currently covering ITRI (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for ITRI in the last 4 months.
Continue this research
Compare ITRI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ITRI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Electronic Equipment & Instruments — fair value, gap to price, and forward P/E.
Compare the value case
Put ITRI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow Outcomes segment revenue and recurring revenue
Grid-edge intelligence supports growth in Outcomes segment revenue.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $92.30
The last 12 months of price, then the range of analyst 12-month targets from today’s $92.30.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Grow Outcomes segment revenue and recurring revenue
Earnings beat indicates strong growth potential in Outcomes segment.
Raised EPS guidance supports financial performance expectations.
Raised EPS outlook supports overall investment thesis.
Sales below estimates may impact future growth expectations.
Strategic collaboration aligns with growth objectives.
Robust growth and positive outlook support investment thesis.